Processing your payment...
Please do not close your browser.

Plasma Protein Therapeutics Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players: Shire (Baxalta), CSL (NSE: COCHINSHIP), Grifols (BME: GRF), Biotest (ETR: BIO)

01 Jul, 2022 | 133 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Plasma Protein Therapeutics Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 7.1% during the review period (2022 to 2029).

Plasma Protein Therapeutics Market Overview

Plasma protein therapies are used to treat a variety of illnesses, including hemostasis. The market trends are being considerably influenced by rising awareness of the use of various protein components that are extremely effective and support a modernized approach of therapy.

Increasing acceptance of plasma treatment in neurology and other therapeutic indications, as well as increased frequency of autoimmune illnesses, immune deficiency disorders, and bleeding disorders, are likely to drive market growth over the forecasted period. The senior population is growing, making them more vulnerable to neurological problems. Additionally, market growth is fueled by pharmaceutical and biotechnology businesses boosting their investments in research and development activities. The plasma protein treatment segment's continued research and development is projected to drive its acceptance through a variety of applications. The increased use of therapeutic protein medicines to treat a wide range of clinical complaints is likely to boost the market's potential in the coming years.

The approval of a number of innovative plasma-derived medicines around the world is expected to boost demand. The aforementioned factors are expected to promote the growth of the Plasma Protein Therapeutics Market over the estimated period. Furthermore, the market is likely to rise due to the approval of plasma products across different indications, increased R&D activities, and a strong demand for innovative therapeutic choices. Life expectancy has increased as a result of technological breakthroughs, advantageous reimbursement policies, and a better standard of living, resulting to an increase in the senior population. IG produced from plasma is also utilized to treat a variety of autoimmune and inflammatory illnesses.

What is our Plasma Protein Therapeutics Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 7.1 % during the review period (2022 to 2029).

 

By Type

  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others

 

By Application

  • Hemophilia
  • PID
  • Others

 

 By Companies

 

 

 

 

Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

133

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Frequently Asked Questions

What is the study period of this market?

The Plasma Protein Therapeutics Market is studied from 2017 - 2029.

What is the growth rate of Plasma Protein Therapeutics Market?

The Plasma Protein Therapeutics Market is growing at a CAGR of 7.1 % over the next forecast years.

Who are the key players in Plasma Protein Therapeutics Market?

Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada, Terumo BCT

What region does this Plasma Protein Therapeutics Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Plasma Protein Therapeutics Market?

Coagulation Factor, Immune Globulin, Albumin, Others

What are the major end-use applications of Plasma Protein Therapeutics Market?

Hemophilia, PID, Others

Who are the Major Players in Plasma Protein Therapeutics Market?

The Plasma Protein Therapeutics Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Shire (Baxalta), CSL (NSE: COCHINSHIP), Grifols (BME: GRF), Biotest (ETR: BIO),Octapharma, Kedrion, LFB Group,BPL, RAAS, CBPO, Hualan Bio, Kamada, Terumo BCT and others.

Industry News:

In March 2022, Food and Drug Administration (FDA) cleared the new plasma collection system Rika Plasma Donation System (Rika), developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company. Rika is a next-generation automated technology focused on the experience of plasma center employees and donors.

In January 2022, Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies, based in Elstree, UK, its ALBUMINEX received BPL license to market the product in China. The National Medical Products Administration (NMPA) for China has granted the license for ALBUMINEX® 25% product.

What are the major Applications, Types and Regions for Plasma Protein Therapeutics Market?

By Type, it is segmented into

  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others

By Applications it is segmented into

  • Hemophilia
  • PID
  • Others

Plasma Protein Therapeutics Market Regional Analysis

North America is expected to dominate the global plasma protein therapies market Throughout the projected period. Factors such as the rising prevalence and incidence of autoimmune and neurological illnesses are driving market expansion. The United States is likely to be the region's largest market. The plasma-derived protein therapeutics market is predicted to develop at the quickest rate in Asia Pacific. The market in this region is expected to develop due to rising demand for better treatment options and rising per capita expenditure.

The market for Plasma Protein Therapeutics in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Plasma Protein Therapeutics Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Plasma Protein Therapeutics Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Coagulation Factor, Immune Globulin, Albumin, Others) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Hemophilia, PID, Others) 2021/2022
    4. Impact of COVID-19 on the Plasma Protein Therapeutics Market
    5. Production Share of Plasma Protein Therapeutics, By Region, 2022
    6. Key Industry Developments
  5. Global Plasma Protein Therapeutics Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Hemophilia
      2. PID
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Coagulation Factor
      2. Immune Globulin
      3. Albumin
      4. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Shire (Baxalta)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. CSL
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Grifols
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Octapharma
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla